NCT06817044View on ClinicalTrials.gov

Optimising Screening for the Cardiotoxic Effects of Cancer Therapy

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

September 30, 2018

Conditions
Ventricular DysfunctionCardiotoxicityChemotherapeutic Toxicity
Trial Locations (1)

Unknown

Barts Heart Centre, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT06817044 - Optimising Screening for the Cardiotoxic Effects of Cancer Therapy | Biotech Hunter | Biotech Hunter